Wall Street is becoming convinced that both the White House and Beijing are willing to engage in a protracted trade war that could begin to hit consumers and slow global...Market Insiderread more
President Donald Trump was expected to deliver remarks Thursday afternoon on supporting America's farmers and ranchersPoliticsread more
Trade tensions with China may be a boon to the U.S. housing market. Investors are rushing into the relative safe-haven of the bond market, cause the yield on the U.S. 10-year...Real Estateread more
Stocks fell sharply on Thursday as U.S.-China trade worries persisted with more companies suspending business with Chinese telecom giant Huawei.Marketsread more
Oracle co-founder Larry Ellison disclosed a $1 billion stake in Tesla in late December. It's now worth about $580 million.Technologyread more
Investors trying to get a gauge on the state of U.S.-China trade relations should look at shares of big chipmakers, according to Ned Davis Research.Marketsread more
The e-mail's optimistic tone helped Tesla shares turn positive for the first time in seven days.Technologyread more
J.P. Morgan Chase has cut ties with Purdue Pharma LP over the OxyContin maker's alleged role in the U.S. opioid crisis, forcing it to find a new bank to manage cash and bill...Banksread more
Oil prices tumble as the market braces for a prolonged U.S.-China trade war and on signs the U.S. is willing to negotiate with Iran.Energy Commoditiesread more
Conservative nonprofit dark money group American Action Network dramatically increased its media spending during the tax reform debate of 2017 and the buildup to the 2018...Politicsread more
Stocks are plummeting on Thursday as trade fears wash over Wall Street again. Five experts reveal what they're watching.Trading Nationread more
Los Angeles, April 28, 2015 (GLOBE NEWSWIRE) -- BioCorRx, Inc.(BICX) announces MSNBC segment featuring Brady Granier, COO andinterim CEO, alongside Start Fresh Program and Growing Pains alum,Jeremy Miller. The two were interviewed by Tamron Hall ofNewsNation to discuss Jeremy's success with the Start FreshProgram, a medication-assisted treatment program developed byBioCorRx that is used to treat alcohol and opioid addiction. The MSNBC segment originally aired on April 21, 2015 and can beviewed online here.
This television appearance followed a recent endorsement ofmedication-assisted treatment (MAT) for alcohol addiction by theSubstance Abuse and Mental Health Services Administration (SAMHSA)and the National Institute on Alcohol Abuse and Alcoholism(NIAAA). According to an article found here from Healio.com earlier this month, the groupscollaborated on assembling a panel of experts to review data on theefficacy of treatment protocols that use medication in thetreatment of alcoholism. The panel's findings showed drugssuch as Naltrexone, the FDA approved pharmaceutical used in thespecially formulated implant that is part of the Start FreshProgram, to be effective in the treatment of alcohol abuse as wellas managing relapse.
"We are pleased to see medication-assisted treatment, especiallywhen it comes to Naltrexone, getting the attention it deserves thathas been long overdue. We have always believed that drugslike Naltrexone, which is used in the implant portion of the StartFresh Program, have massive potential for helping addictedindividuals reach the road to recovery when coupled withtherapy. With institutions such as SAMHSA and NIAAA endorsingthe use of medication-assisted treatment, we can hope that thenumber of families and individuals helped by programs such as ourswill increase dramatically. We believe that we are seeing afundamental shift in how addiction is classified and treated. Nowit's time for the healthcare providers, payors, and all levels ofgovernment to help to bring more education and awareness to thisevolution in addiction treatment," stated Granier.
Visit BioCorRx, Inc.'s investor relations website www.BICXcorp.com to receive the mostup to date company information.
About BioCorRx, Inc.
BioCorRx, Inc. ® (OTCQB: BICX) is an addiction treatment andrehabilitation company offering a unique approach to the treatmentof substance abuse addiction. The Start Fresh Program®, amedication-assisted treatment (MAT) program, consists of twocomponents. The first component of the program consists of anoutpatient implant procedure performed by a licensed physician. Theimplant delivers therapeutic levels of the drug Naltrexone, anopioid antagonist that significantly reduces physical cravings foralcohol and opioids, into the body. The second component of theprogram developed by BioCorRx, Inc. is a one on one coachingprogram specifically tailored for the treatment of alcoholism andother substance abuse addictions. Clinic reports show that thetreatment program can be successful for individuals who completethe program. For more information on BICX, visit www.BICXCorp.com orwww.StartFreshProgram.com.
2014 was a pivotal year for BioCorRx, Inc. Clinics usingthe Start Fresh Program collectively saw a 402% increase inpatients treated from 2013 to 2014. Over the course of 2015,the company plans to continue the process of developing more newterritories with its partners.
Number of clinics at the end of each quarter offering the StartFresh Program
-Q1, 2014 -- 5 clinics offering the Start Fresh Program
-Q2, 2014 -- 6 clinics offering the Start Fresh Program
-Q3, 2014 -- 6 clinics offering the Start Fresh Program
-Q4, 2014 -- 10 clinics offering the Start Fresh Program
-Q1, 2015 - 13 clinics offering the Start Fresh Program
-Q2, 2015 to date - 14 clinics offering the Start FreshProgram
Safe Harbor Statement
The information in this release includes forward-lookingstatements. These forward-looking statements generally areidentified by the words "believe," "project," "estimate," "become,""plan," "will," and similar expressions. These forward-lookingstatements involve known and unknown risks as well asuncertainties. Although the Company believes that its expectationsare based on reasonable assumptions, the actual results that theCompany may achieve may differ materially from any forward-lookingstatements, which reflect the opinions of the management of theCompany only as of the date hereof.
CONTACT: Investor Relations SmallCapVoice.com, Inc. 512-267-2430